Breaking News

Ixaka and Minaris sign tech transfer and GMP manufacturing agreement

The two companies have signed the agreement for Ixaka lead autologous multi-cell therapy

Merck opens $63m CDMO facility to handle HPAPIs

The industry expert has announced that its Life Science business sector has doubled its highly potent active pharmaceutical ingredients (HPAPI) pro...

Curia and Replicate Bioscience to collaborate on srRNA platform

The two US-based companies have entered a strategic collaboration to create a groundbreaking development platform for Self-Replicating RNA (srRNA)

A risk mitigation approach to detecting and quantifying metals in APIs

If trace quantities of metals are present in active pharmaceutical ingredients (APIs) or final drug products, they have the potential to adversely...

DFE Pharma opens its new centre of excellence in India to provide fast-track formulation services

The new Closer to the Formulator (C2F) centre offers DFE Pharma’s excipient expertise to help pharmaceutical companies achieve right-first-time for...

What can Manufacturing Chemist do for you?

Subscribe to Manufacturing Chemist magazine for updates on the pharmaceutical industry

CBD: the new frontier in medical science

Early stage drug development plays an important role in expanding treatment options that will support the health of patients globally. To create be...

Manufacturing Chemist LIVE 2022 in review (part I)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

AGC Biologics invests in viral vector suspension production capacity

The company has announced the expansion that more than doubles the site's viral vector capacity

CDMO and vector specialist join forces to improve VV production efficiency

ProteoNic and NecstGen have recognised the need to increase viral titres and optimise production processes in order to improve the feasibility of v...

Innovative new process used to produce a diabetes and weight loss drug

Camilla Koller, Marketing Communications Associate, tells Dr Kevin Robinson how Bachem has used its extensive experience and expertise in peptide s...

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider when embarking on an HPAPI proj...

Ilya Pharma strengthens supply chain with strategic investment

The immunotherapy expert has acquired Nordic Bioanalysis located at the previous AstraZeneca site in south of Stockholm

Developments in global pharmaceutical excipients in the next 3–5 years: part II

Key themes that will shape the excipient landscape in the near future will include regulations, innovation, economics and sustainability, says Dr I...

Biocytogen joins forces with CtM Bio to combine antibody tech

The companies have collaborated to benefit from Biocytogen's proprietary TCR-mimic antibody development platform and CtM's proprietary T cell engag...

Developments in global pharmaceutical excipients in the next 3–5 years: part I

Key themes that will shape the excipient landscape in the near future will include regulations, innovation, economics and sustainability, says Dr I...